Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors.
Chen Y, Li Y, Guan Y, Huang Y, Lin J, Chen L, Li J, Chen G, Pan LK, Xia X, Xu N, Chang L, Guo Z, Pan J, Yi X, Chen C.
Chen Y, et al. Among authors: lin j.
Mol Oncol. 2020 Sep;14(9):2096-2110. doi: 10.1002/1878-0261.12739. Epub 2020 Jun 30.
Mol Oncol. 2020.
PMID: 32502294
Free PMC article.